COVID-19. COVID-19, virus identified
Conditions
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 to 60 years Diagnosis confirmation by the cooperative infectious disease specialist in the project Patient's consent to participate in the project With inpatient clinical criteria (fever above 38° C or severe cough or shortness of breath or respiratory rate more than 24 per minute or oxygen saturation lower than 93%) Positive PCR
Exclusion criteria
Exclusion criteria: Current incidence of coagulopathy, obesity, deep vein thrombosis, vertebral fracture or herniated disc Need for current hospitalization in ICU Pregnancy Breastfeeding Hearth failure Chronic renal failure Receive chemotherapy Receive corticosteroids Immune deficiency Open wound at the site of cupping
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dyspnea. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of cupping. Method of measurement: By using a pulse oximeter and asking the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: Mercury thermometer (oral).;Muscular pain. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the cupping. Method of measurement: By asking the patient and the Visual Analog Scale (VAS) score.;Dry cough. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the cupping. Method of measurement: By asking the patient.;ESR. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Sed rate device.;CRP. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Agglutination kit.;Cell blood count. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Cell Counter device.;Chest X-ray. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Radiology set.;Chest CT scan. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day, if requested by the treating physician, it will be recorded. Method of measurement: CT scan set. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Tahermohammadi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed